References
- Choi YH, Neef K, Reher M, Liakopoulos OJ, Zeriouh M, Wittwer T, . The influence of pre-operative risk on the number of circulating endothelial progenitor cells during cardiopulmonary bypass. Cytotherapy. 2010;12:79–87.
- Nathan N, Preux PM, Feiss P, Denizot Y. Plasma interleukin 4, 10 and 13 concentrations and complications after coronary artery bypass grafting surgery. J Cardiothorac Vasc Surg. 2000;14:156–60.
- Denizot Y, Lorgeot V, Cornu E, Nathan N. Plasma leukemia inhibitory factor, interleukin-6 and soluble interleukin-6 receptor levels during cardiopulmonary bypass with extracorporeal circulation. Cytokine. 1998;10:303–6.
- Denizot Y, Guglielmi L, Cornu E, Nathan N. Alterations in plasma angiogenic growth factor concentrations after coronary artery bypass graft surgery: relationships with post-operative complications. Cytokine. 2003;24:7–12.
- Denizot Y, Karoutsos S, Nathan N. Differential alterations in plasma colony-stimulating factor concentrations after coronary artery bypass graft surgery with extracorporeal circulation. Cytokine. 2001;13:314–16.
- Smith SK. Angiogenesis, vascular endothelial growth factor and the endometrium. Human Reprod Update. 1998;4:509–19.
- Denizot Y, Leguyader A, Cornu E, Laskar M, Orsel I, Vincent C, Nathan N. Alterations in plasma soluble vascular endothelial growth factor receptor-1 (sFlt-1) concentrations during coronary artery bypass graft surgery: relationships with post operative complications. J Cardiothor Surg. 2008; 3:16.